Default Category
-
The Renault KWID: Disrupting India's Hatchback Market
Jones Mathew; Banasree Dey; Sandeep PuriCase IVEY-9B17A023-EMarketing, StrategyThe Renault KWID was successfully launched in India in the entry-level car segment as a new competitor for the Maruti Suzuki Alto, the largest-selling passenger car in the country. By August 2016, the market leader’s market share had fallen to 40.6 per cent from 48.5 per cent earlier that year, while the Renault KWID gained a market share of about 19.8 per cent. Despite the KWID’s remarkable success, however, Renault’s strategy for the future nee...Starting at €8.20
-
The Vanca: Dilemmas of an E-commerce Entrepreneurial Startup
Jones Mathew; Pinaki DasguptaCase IVEY-9B15M035-EEntrepreneurship, StrategyThe Vanca, an online apparel brand and supplier to online retailers (“e-tailers”) has achieved a fair degree of success by focusing on quality, innovative designs, “fast fashion” and a strong network with its customers. Management is looking to grow the business further; however, there are challenges such as uneven sales across some of its product ranges, maintaining its competitive edge and the threat from private labels being introduced by the ...Starting at €8.20
-
Tiktauli de Corps: A Branding Dilemma
Jones Mathew; Banasree Dey; Sandeep PuriCase IVEY-9B18A066-EEntrepreneurship, MarketingIn July 2018, the chief executive officer of Tiktauli De Corps (TDC) was thinking about the branding strategy of the company. Founded in India in August 2012 as a casual wear apparel brand, TDC had grown rapidly. The company featured three main business lStarting at €8.20
-
China: "To Get Rich Is Glorious," Teaching Note
Vietor, Richard H.K.; Dessain, VincentTeaching Note HBS-708008-EEconomicsTeaching Note to 707022.Starting at €0.00
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
The Vanca: Reworking Digital Marketing Strategy
Jones Mathew; Banasree DeyCase IVEY-9B17A011-EEntrepreneurship, Marketing, StrategySince its inception in 2011, The Vanca, an Indian e-commerce brand selling women’s Western apparel, had come a long way. After overcoming initial problems typical of many entrepreneurial start-ups, The Vanca made significant progress in terms of sales. However, its brand-building activities had not been very successful. Having concentrated entirely on online digital marketing, the company did not see the expected results. The digital space offere...Starting at €8.20
-
Pearson Affordable Learning Fund
Chu, Michael; Dessain, Vincent; Maslauskaite, KristinaCase HBS-315109-EAn in-house venture capital fund for affordable private schools at the base of the pyramid established by Pearson, the world's largest education company, PALF sought to invest in business models providing superior educational outcomes in emerging markets on a profitable and scalable basis. With Pearson's overall strategy shifting from the developed to the developing world and from a supplier of books to a host of other learning products and servi...Starting at €8.20
-
lebua: A Thai Luxury Hotel’s Post-Pandemic Dilemmas
Jones Mathew; Sujata Khandai; Sandeep PuriCase IVEY-W25819-ELeadership and People Management, Marketinglebua Hotels & Resorts, based in Bangkok, Thailand, and headed by chief executive officer Deepak Ohri, is a much awarded luxury hotel chain. Since the early 2000s, it exposed the traditionally slow-moving luxury hospitality industry to a slew of path-breaking innovations. Before the COVID-19 pandemic, Ohri had taken unorthodox paths to defining luxury hospitality. However, as the pandemic began to ebb, he had to convince the industry of his visio...Starting at €8.20
-
La Roche-Posay: Growing L'Or al's Active Cosmetics Brand
Avery, Jill; Dessain, Vincent; Hjortshoej, Mette FuglsangCase HBS-520035-EMarketingAs 2018 neared its end, Laetitia Toupet, international general manager of L'Or al's La Roche-Posay brand reflected on the brand's achievements over the past year. At 1 billion in revenue, La Roche-Posay had recently become the number one dermocosmetics brand in the world. While Toupet was pleased with this feat, she believed that the brand was at a critical juncture. It was time to make some significant marketing decisions related to brand po...Starting at €8.20